As Therapeutic Modalities Expand, Genomic Profiling Must Keep Pace
The boundaries of what’s considered “druggable” are shifting as advances in cell and gene therapies expand the possibilities for cancer treatment. Expanded insights can open new avenues for biomarker research and therapeutic discovery.